Intrinsiqq
NeueHealth, Inc. logo

NeueHealth, Inc. (NEUE) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Dec 2022.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Dec 2022
Dec 14, 2022

Get an email when NEUE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 2, 2025No plan
    Scott D Sandell
    Director · sold 4,195 at avg $6.75
    $28k
    100% of stake
  • Oct 2, 2025No plan
    Anthony A. Florence Jr.
    Director · sold 4,195 at avg $6.75
    $28k
    100% of stake
  • Oct 2, 2025No plan
    Paul Edward Walker
    Director · sold 3,915 at avg $6.75
    $26k
    100% of stake
  • Oct 2, 2025No plan
    Carmen Chang
    Director · sold 3,915 at avg $6.75
    $26k
    100% of stake
  • Oct 2, 2025No plan
    Ali Behbahani
    Director · sold 3,915 at avg $6.75
    $26k
    100% of stake
  • Oct 2, 2025No plan
    Rick Yang
    Director · sold 3,635 at avg $6.75
    $25k
    100% of stake
  • Oct 2, 2025No plan
    Edward T Mathers
    Director · sold 3,635 at avg $6.75
    $25k
    100% of stake
  • Oct 2, 2025No plan
    Forest Baskett
    Director · sold 840 at avg $6.75
    $6k
    100% of stake
  • Oct 2, 2025No plan
    NEA Partners 18 Vge, L.p.
    Large holder · sold 3,355 at avg $6.75
    $23k
    100% of stake
  • Oct 2, 2025No plan
    NEA Partners 17, L.p.
    Large holder · sold 280 at $6.75
    $2k
    100% of stake
  • Oct 2, 2025No plan
    New Enterprise Associates 16, L.p.
    Large holder · sold 280 at $6.75
    $2k
    100% of stake
  • Oct 2, 2025No plan
    NEA 15 GP, LLC
    Large holder · sold 280 at $6.75
    $2k
    100% of stake
  • Oct 2, 2025No plan
    New Enterprise Associates 15, L.p.
    Large holder · sold 280 at $6.75
    $2k
    100% of stake
  • May 12, 2025No plan
    Jeffrey J Scherman
    Chief Accounting Officer · sold 112 at $6.76
    $757
    0.9% of stake
  • May 12, 2025No plan
    Jay Matushak
    Chief Financial Officer · sold 472 at $6.76
    $3k
    1.2% of stake
  • Mar 13, 2025 – Mar 14, 2025No plan
    Jeffrey J Scherman
    Chief Accounting Officer · sold 1,373 at avg $6.58
    $9k
    10% of stake
  • Mar 13, 2025 – Mar 14, 2025No plan
    Jeffery Michael Craig
    GC & Corporate Secretary · sold 3,494 at avg $6.58
    $23k
    15% of stake
  • Mar 13, 2025 – Mar 14, 2025No plan
    Tomas Orozco
    EVP, Consumer Care · sold 4,766 at avg $6.58
    $31k
    14% of stake
  • Mar 13, 2025 – Mar 14, 2025No plan
    Jay Matushak
    Chief Financial Officer · sold 5,990 at avg $6.58
    $39k
    13% of stake
  • Mar 13, 2025 – Mar 14, 2025No plan
    George Lawrence Mikan III
    CEO & President · sold 48,336 at avg $6.58
    $318k
    16% of stake
  • Mar 11, 2025 – Mar 12, 2025No plan
    Jeffrey J Scherman
    Chief Accounting Officer · sold 802 at avg $6.89
    $6k
    5.6% of stake
  • Mar 11, 2025 – Mar 12, 2025No plan
    Jeffery Michael Craig
    GC & Corporate Secretary · sold 1,148 at avg $6.92
    $8k
    4.6% of stake
  • Mar 11, 2025 – Mar 12, 2025No plan
    Tomas Orozco
    EVP, Consumer Care · sold 1,917 at avg $6.90
    $13k
    5.3% of stake
  • Mar 11, 2025 – Mar 12, 2025No plan
    Jay Matushak
    Chief Financial Officer · sold 2,447 at avg $6.90
    $17k
    5.0% of stake
  • Mar 11, 2025 – Mar 12, 2025No plan
    George Lawrence Mikan III
    CEO & President · sold 16,927 at avg $6.91
    $117k
    5.4% of stake
  • Mar 7, 2025 – Mar 10, 2025No plan
    Jeffrey J Scherman
    Chief Accounting Officer · sold 804 at avg $7.16
    $6k
    8.3% of stake
  • Mar 7, 2025 – Mar 10, 2025No plan
    Jeffery Michael Craig
    GC & Corporate Secretary · sold 1,242 at avg $7.19
    $9k
    10% of stake
  • Mar 7, 2025 – Mar 10, 2025No plan
    Tomas Orozco
    EVP, Consumer Care · sold 640 at avg $7.19
    $5k
    5.1% of stake
  • Mar 7, 2025 – Mar 10, 2025No plan
    Jay Matushak
    Chief Financial Officer · sold 2,044 at avg $7.18
    $15k
    7.7% of stake
  • Mar 7, 2025 – Mar 10, 2025No plan
    George Lawrence Mikan III
    CEO & President · sold 28,264 at avg $7.18
    $203k
    13% of stake
  • Jan 6, 2025No plan
    Jeffrey J Scherman
    Chief Accounting Officer · sold 1,368 at $7.33
    $10k
    19% of stake
  • Jan 6, 2025No plan
    Jeffery Michael Craig
    GC & Corporate Secretary · sold 2,486 at $7.33
    $18k
    25% of stake
  • Jan 6, 2025No plan
    Jay Matushak
    Chief Financial Officer · sold 4,970 at $7.33
    $36k
    22% of stake
  • Jan 6, 2025No plan
    Tomas Orozco
    EVP, Consumer Care · sold 1,233 at $7.33
    $9k
    14% of stake
  • Jan 6, 2025No plan
    George Lawrence Mikan III
    CEO & President · sold 31,798 at $7.33
    $233k
    18% of stake
  • Dec 17, 2024No plan
    George Lawrence Mikan III
    CEO & President · sold 16,803 at $4.18
    $70k
    17% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NEUE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

Spot a number that looks wrong? Check it in NEUE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NEUE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.